BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11441312)

  • 41. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma.
    Chen RC; Liao LY; Wang CS; Chen WT; Wang CK; Li YH; Tu HY; Chen PH
    AJR Am J Roentgenol; 2003 Dec; 181(6):1647-52. PubMed ID: 14627590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection.
    Seror O; N'Kontchou G; Haddar D; Dordea M; Ajavon Y; Ganne N; Trinchet JC; Beaugrand M; Sellier N
    Radiology; 2005 Jan; 234(1):299-309. PubMed ID: 15564388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous treatment of liver metastases.
    Adam A
    Acta Gastroenterol Belg; 2000; 63(2):163-4. PubMed ID: 10925452
    [No Abstract]   [Full Text] [Related]  

  • 45. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC).
    Macías-García F; Vallejo-Senra N; Baleato-González S; Fernández-Castroagudín J; Molina-Pérez E; Domínguez-Muñoz J
    Rev Esp Enferm Dig; 2013 Feb; 105(2):110-2. PubMed ID: 23659512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of liver tumors with ethanol injection].
    Kaláb M
    Vnitr Lek; 1997 Mar; 43(3):180-3. PubMed ID: 9221582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver-directed treatment modalities for primary and secondary hepatic tumors.
    Yamane B; Weber S
    Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma.
    Da Ines D; Buc E; Petitcolin V; Flamein R; Lannareix V; Achim A; Garcier JM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1301-5. PubMed ID: 20598566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
    [No Abstract]   [Full Text] [Related]  

  • 52. [Imaging-guided therapy of primary tumors of the liver].
    Fuertes Guirò F; Vantadori MG; D'Urbano C
    Minerva Chir; 1996 May; 51(5):321-8. PubMed ID: 9072740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local injection therapy for hepatocellular carcinoma.
    Lin XD; Lin LW
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):16-21. PubMed ID: 16481276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Local treatment of liver tumors].
    Pless TK; Skjoldbye BO
    Ugeskr Laeger; 2008 Apr; 170(16):1348-9. PubMed ID: 18433596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of malignant hepatic tumors using percutaneous hot saline injections. Feasibility study and preliminary results].
    Veltri A; Martina C; Bonenti G; Dore D; Cirillo S; Grosso M; Fava C
    Radiol Med; 1995 Oct; 90(4):463-9. PubMed ID: 8552825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous ablation of hepatocellular carcinoma.
    Lencioni R; Della Pina C; Crocetti L; Cioni D
    Recent Results Cancer Res; 2006; 167():91-105. PubMed ID: 17044299
    [No Abstract]   [Full Text] [Related]  

  • 58. [Non-Surgical tumor ablation of hepatocellular carcinoma].
    Koike Y; Omata M
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laparoscopic US-guided percutaneous ethanol ablation of hepatocellular carcinoma.
    Mehta M; Asch MR; Gallinger S
    J Vasc Interv Radiol; 1998; 9(4):583-7. PubMed ID: 9684827
    [No Abstract]   [Full Text] [Related]  

  • 60. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.